Atria Research and Global Health Institute's Khadija Rejto examines how longer lifespans are reshaping wealth transfer, philanthropy and healthcare investment. Rejto argues that longevity is a legacy challenge that will determine whether prevention, brain health and care infrastructure innovations become broadly accessible or advantages reserved for those who can afford them.
Atria Research and Global Health Institute's Khadija Rejto examines how longer lifespans are reshaping wealth transfer, philanthropy and healthcare investment.
Rejto argues that longevity is a legacy challenge that will determine whether prevention, brain health and care infrastructure innovations become broadly accessible or advantages reserved for those who can...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Atria Research and Global Health Institute's Khadija Rejto examines how longer lifespans are reshaping wealth transfer, philanthropy and healthcare investment. Rejto argues that longevity is a legacy challenge that will determine whether prevention, brain health and care infrastructure innovations become broadly accessible or advantages reserved for those who can afford them.
Open the app view to save this story, compare related coverage, and continue from the same source.